Your browser doesn't support javascript.
loading
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease.
Rider, David A; Eisermann, Mona; Löffler, Kathrin; Aleku, Manuela; Swerdlow, Daniel I; Dames, Sibylle; Hauptmann, Judith; Morrison, Eliot; Lindholm, Marie Wikström; Schubert, Steffen; Campion, Giles.
Affiliation
  • Rider DA; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany. Electronic address: d.rider@silence-therapeutics.com.
  • Eisermann M; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Löffler K; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Aleku M; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Swerdlow DI; Silence Therapeutics PLC, 72 Hammersmith Road, London, W14 8TH, London, UK.
  • Dames S; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Hauptmann J; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Morrison E; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Lindholm MW; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Schubert S; Silence Therapeutics GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
  • Campion G; Silence Therapeutics PLC, 72 Hammersmith Road, London, W14 8TH, London, UK.
Atherosclerosis ; 349: 240-247, 2022 05.
Article in En | MEDLINE | ID: mdl-35400495
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hyperlipidemias Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Atherosclerosis Year: 2022 Document type: Article Country of publication: Ireland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hyperlipidemias Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Atherosclerosis Year: 2022 Document type: Article Country of publication: Ireland